Traumatic Brain Injury

Traumatic brain injury (TBI) is the leading cause of death and disability in the United States. About 70 – 90% of TBI cases are classified as mild, and up to 25% of affected patients will not recover and suffer chronic neurocognitive impairments. The main pathology in these cases involves diffuse brain injuries, which are hard to detect by anatomical imaging yet noticeable in functional imaging that measures tissue metabolism in the brain.

Many studies show the effectiveness of HBOT in improving brain function and quality of life in mild traumatic brain injury (mTBI) patients suffering chronic neurocognitive impairments. The common conclusion is that HBOT can induce neuroplasticity, leading to repair of chronically impaired brain functions and improved quality of life in mTBI patients with prolonged post-concussion syndrome (PCS) at late chronic stage. Studies also reveal that HBOT can reduce cognitive impairment related to memory performance and connectivity using functional MRI.

At TBI Therapy, HBOT is used to treat brain injury as part of a regenerative therapy protocol: the TBI Therapy Protocol. Patient sessions in a hyperbaric chamber are designed to stimulate growth factors promoted in PRP therapy and the production of stem cells in regenerative cellular therapy.